Impact of institutional prophylaxis guidelines on rates of pediatric venous thromboembolism following trauma-A multicenter study from the pediatric trauma society research committee.

Autor:	Labuz DF; From the Division of Pediatric Surgery, Department of Surgery (D.F.L., J.T., L.S., X.Y.H., A.C., N.A.H., M.A.J.), Oregon Health & Science University, Portland, Oregon; Department of Surgery (C.W.M.), Madigan Army Medical Center, Tacoma, Washington; Department of Pediatric Surgery (M.A.E.Jr.), Mary Bridge Children's Hospital, Tacoma, Washington; Division of Pediatric Surgery, Department of Surgery (M.D.H., M.A.C.), University of Massachusetts Medical School, Worcester, Massachusetts; Division of Pediatric General and Thoracic Surgery (M.K., R.A.F.Jr.), Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Division of Pediatric Surgery (A.M.V.), Texas Children's Hospital, Houston, Texas; Division of Pediatric Surgery, Department of Surgery (T.M.A., D.B.K.), Mayo Clinic, Rochester, Minnesota; Division of Pediatric Surgery (A.S., A.C.), Floating Hospital for Children at Tufts Medical Center, Boston, Massachusetts; Division of Critical Care (A.O., A.Z.), Children's Hospital and Clinics of Minnesota, Minneapolis, Minnesota; Division of Pediatric Surgery, Department of Surgery (A.G., M.K.), University of Tennessee Health Sciences Center, Memphis, Tennessee; and Division of Pediatric Surgery (M.A.J.), Randall Children's Hospital at Legacy Emanuel, Portland, Oregon., Tobias J, Selesner L, Han X, Cunningham A, Marenco CW, Escobar MA Jr, Hazeltine MD, Cleary MA, Kotagal M, Falcone RA Jr, Vogel AM, MacArthur T, Klinkner DB, Shah A, Chernoguz A, Orioles A, Zagel A, Gosain A, Knaus M, Hamilton NA, Jafri MA
Jazyk:	angličtina
Zdroj:	The journal of trauma and acute care surgery [J Trauma Acute Care Surg] 2023 Sep 01; Vol. 95 (3), pp. 341-346. Date of Electronic Publication: 2023 Mar 06.
DOI:	10.1097/TA.0000000000003918
Abstrakt:	Background: A paucity of data exists with regard to the incidence, management, and outcomes of venous thromboembolism (VTE) in injured children. We sought to determine the impact of institutional chemoprophylaxis guidelines on VTE rates in a pediatric trauma population. Methods: A retrospective review of injured children (≤15 years) admitted between 2009 and 2018 at 10 pediatric trauma centers was performed. Data were gathered from institutional trauma registries and dedicated chart review. The institutions were surveyed as to whether they had chemoprophylaxis guidelines in place for high-risk pediatric trauma patients, and outcomes were compared based on the presence of guidelines using χ 2 analysis ( p < 0.05). Results: There were 45,202 patients evaluated during the study period. Three institutions (28,359 patients, 63%) had established chemoprophylaxis policies during the study period ("Guidelines"); the other seven centers (16,843 patients, 37%) had no such guidelines ("Standard"). There were significantly lower rates of VTE in the Guidelines group, but these patients also had significantly fewer risk factors. Among critically injured children with similar clinical presentations, there was no difference in VTE rate. Specifically within the Guidelines group, 30 children developed VTE. The majority (17/30) were actually not indicated for chemoprophylaxis based on institutional guidelines. Still, despite protocols only one VTE patient in the guidelines group who was indicated for intervention ended up receiving chemoprophylaxis prior to diagnosis. No consistent ultrasound screening protocol was in place at any institution during the study. Conclusion: The presence of an institutional policy to guide chemoprophylaxis for injured children is associated with a decreased overall frequency of VTE, but this disappears when controlling for patient factors. However, the overall efficacy is impacted by a combination of deficits in guideline compliance and structure. Further prospective data are needed to help determine the ideal role for chemoprophylaxis and protocols in pediatric trauma. Level of Evidence: Therapeutic/Care Management; Level IV. (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu